XML 53 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Investments Schedule of Investments in Marketable Securities (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2019
Apr. 01, 2018
Mar. 31, 2019
Apr. 01, 2018
Jul. 01, 2018
Schedule of Available-for-sale Securities [Line Items]          
Revenue from Related Parties     $ 48,200 $ 65,100  
Purchases Of Finished Products From Equity Method Investees     94,100 86,800  
Equity Method Investment, Summarized Financial Information, Current Assets $ 142,352   142,352   $ 150,382
Equity Method Investment, Summarized Financial Information, Revenue 71,593 $ 78,271 227,639 234,664  
Equity Method Investment, Summarized Financial Information, Cost of Sales 55,048 59,992 178,125 179,794  
Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) 16,545 18,279 49,514 54,870  
Equity Method Investment, Summarized Financial Information, Net Income (Loss) 3,884 $ 4,444 11,799 $ 14,202  
Equity Method Investment, Summarized Financial Information, Noncurrent Assets 40,210   40,210   45,186
Equity Method Investment, Summarized Financial Information, Assets 182,562   182,562   195,568
Equity Method Investment, Summarized Financial Information, Liabilities [Abstract]          
Equity Method Investment, Summarized Financial Information, Current Liabilities 55,083   55,083   54,007
Equity Method Investment, Summarized Financial Information, Noncurrent Liabilities 15,969   15,969   20,027
Equity Method Investment, Summarized Financial Information, Liabilities 71,052   71,052   74,034
Equity Method Investment, Summarized Financial Information, Equity Excluding Noncontrolling Interests $ 111,510   $ 111,510   $ 121,534